These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 27280602)

  • 21. Highly conserved sequences for human neutralization epitope on hemagglutinin of influenza A viruses H3N2, H1N1 and H5N1: Implication for human monoclonal antibody recognition.
    Yamashita A; Kawashita N; Kubota-Koketsu R; Inoue Y; Watanabe Y; Ibrahim MS; Ideno S; Yunoki M; Okuno Y; Takagi T; Yasunaga T; Ikuta K
    Biochem Biophys Res Commun; 2010 Mar; 393(4):614-8. PubMed ID: 20152806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccine-induced protection from egg production losses in commercial turkey breeder hens following experimental challenge with a triple-reassortant H3N2 avian influenza virus.
    Kapczynski DR; Gonder E; Liljebjelke K; Lippert R; Petkov D; Tilley B
    Avian Dis; 2009 Mar; 53(1):7-15. PubMed ID: 19431997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relevance of the immunoprecipitation assay to human immunogenicity of influenza vaccines.
    Brandon FB; Havlick MJ; Shillis JL
    Dev Biol Stand; 1977 Jun 1-3; 39():179-85. PubMed ID: 414949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a protective immunity induced by an inactivated influenza H3N2 vaccine after an intratracheal challenge of pigs.
    Bikour MH; Cornaglia E; Elazhary Y
    Can J Vet Res; 1996 Oct; 60(4):312-4. PubMed ID: 8904668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins.
    Wang TT; Tan GS; Hai R; Pica N; Petersen E; Moran TM; Palese P
    PLoS Pathog; 2010 Feb; 6(2):e1000796. PubMed ID: 20195520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of trivalent inactivated influenza vaccines in the cotton rat Sigmodon hispidus model.
    Yim K; Miles B; Zinsou R; Prince G; Boukhvalova M
    Vaccine; 2012 Feb; 30(7):1291-6. PubMed ID: 22210139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing Antigenic Drift of Seasonal Influenza A(H3N2) and A(H1N1)pdm09 Viruses.
    Tewawong N; Prachayangprecha S; Vichiwattana P; Korkong S; Klinfueng S; Vongpunsawad S; Thongmee T; Theamboonlers A; Poovorawan Y
    PLoS One; 2015; 10(10):e0139958. PubMed ID: 26440103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correction: Influenza A Virus NS1 Protein Inhibits the NLRP3 Inflammasome.
    Chung WC; Kang HR; Yoon H; Kang SJ; Ting JP; Song MJ
    PLoS One; 2018; 13(7):e0200624. PubMed ID: 29990347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement of influenza A/Fujian/411/02 (H3N2) virus growth in embryonated chicken eggs by balancing the hemagglutinin and neuraminidase activities, using reverse genetics.
    Lu B; Zhou H; Ye D; Kemble G; Jin H
    J Virol; 2005 Jun; 79(11):6763-71. PubMed ID: 15890915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine.
    Richt JA; Lekcharoensuk P; Lager KM; Vincent AL; Loiacono CM; Janke BH; Wu WH; Yoon KJ; Webby RJ; Solórzano A; García-Sastre A
    J Virol; 2006 Nov; 80(22):11009-18. PubMed ID: 16943300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and immunogenicity of influenza vaccine in HIV-infected children: a randomized, double-blind, placebo controlled trial.
    Madhi SA; Dittmer S; Kuwanda L; Venter M; Cassim H; Lazarus E; Thomas T; Liberty A; Treurnich F; Cutland CL; Weinberg A; Violari A
    AIDS; 2013 Jan; 27(3):369-79. PubMed ID: 23032417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination with whole inactivated virus vaccine affects the induction of heterosubtypic immunity against influenza virus A/H5N1 and immunodominance of virus-specific CD8+ T-cell responses in mice.
    Bodewes R; Kreijtz JH; Hillaire ML; Geelhoed-Mieras MM; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
    J Gen Virol; 2010 Jul; 91(Pt 7):1743-53. PubMed ID: 20335492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correction: Temporal Patterns of Influenza A and B in Tropical and Temperate Countries: What Are the Lessons for Influenza Vaccination?
    Caini S; Andrade W; Badur S; Balmaseda A; Barakat A; Bella A; Bimohuen A; Brammer L; Bresee J; Bruno A; Castillo L; Ciblak MA; Clara AW; Cohen C; Daouda C; de Lozano C; De Mora D; Dorji K; Emukule GO; Fasce RA; Feng L; Ferreira de Almeida WA; Guiomar R; Heraud JM; Holubka O; Huang QS; Kadjo HA; Kiyanbekova L; Kosasih H; Kusznierz G; Lee V; Lara J; Li M; Lopez L; Mai HP; Pessanha HC; Matute ML; Mironenko A; Moreno B; Mott JA; Njouom R; Nurhayati ; Ospanova A; Owen R; Pebody R; Pennington K; Puzelli S; Quynh Le MT; Razanajatovo NH; Rodrigues A; Rudi JM; Venter M; Vernet MA; Wei AL; Wangchuk S; Yang J; Yu H; Zambon M; Schellevis F; Paget J;
    PLoS One; 2016; 11(5):e0155089. PubMed ID: 27135748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infliximab and/or immunomodulators inhibit immune responses to trivalent influenza vaccination in adults with inflammatory bowel disease.
    Hagihara Y; Ohfuji S; Watanabe K; Yamagami H; Fukushima W; Maeda K; Kamata N; Sogawa M; Shiba M; Tanigawa T; Tominaga K; Watanabe T; Fujiwara Y; Hirota Y; Arakawa T
    J Crohns Colitis; 2014 Mar; 8(3):223-33. PubMed ID: 24011513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correction: New Insight into Metal Ion-Driven Catalysis of Nucleic Acids by Influenza PA-Nter.
    Kotlarek D; Worch R
    PLoS One; 2016; 11(7):e0159121. PubMed ID: 27384763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correction: Persistence of Low Pathogenic Influenza A Virus in Water: A Systematic Review and Quantitative Meta-Analysis.
    Dalziel AE; Delean S; Heinrich S; Cassey P
    PLoS One; 2016; 11(12):e0168789. PubMed ID: 27992568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune responses and protection efficacy of a recombinant swinepox virus expressing HA1 against swine H3N2 influenza virus in mice and pigs.
    Xu J; Huang D; Liu S; Lin H; Zhu H; Liu B; Lu C
    Virus Res; 2012 Aug; 167(2):188-95. PubMed ID: 22584406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation and characterization of a cold-adapted attenuated live H3N2 subtype influenza virus vaccine candidate.
    An WQ; Yang PH; Duan YQ; Luo DY; Tang C; Jia WH; Xing L; Shi XF; Zhang YJ; Liu XF; Wang XL
    Chin Med J (Engl); 2009 Dec; 122(23):2880-5. PubMed ID: 20092795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Influenza vaccine stimulation of antibodies to different variants of influenza A virus].
    Naĭkhin AN; Ispolatova AV; Tsybul'skaia NV; Sominina AA; Denisov GM
    Vopr Virusol; 1985; 30(3):290-6. PubMed ID: 4049840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overcoming maternal antibody interference by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of swine influenza virus.
    Wesley RD; Lager KM
    Vet Microbiol; 2006 Nov; 118(1-2):67-75. PubMed ID: 16939702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.